These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22814143)

  • 21. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
    Kaur U; Chakrabarti SS; Gambhir IS
    Curr Drug Saf; 2016; 11(3):267-9. PubMed ID: 27113952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren's syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature.
    Saeki T; Nakajima A; Ito T; Takata T; Imai N; Yoshita K; Kabasawa H; Yamazaki H; Narita I
    Mod Rheumatol; 2018 Sep; 28(5):897-900. PubMed ID: 27142563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study].
    Rack B; Schindlbeck C; Strobl B; Sommer H; Friese K; Janni W
    Dtsch Med Wochenschr; 2008 Feb; 133(7):285-9. PubMed ID: 18253918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.
    Buysschaert M; Cosyns JP; Barreto L; Jadoul M
    Nephrol Dial Transplant; 2003 Apr; 18(4):826-9. PubMed ID: 12637657
    [No Abstract]   [Full Text] [Related]  

  • 26. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Zoledronate-associated end stage renal failure and hypocalcaemia].
    Ramazzina C; Zysset Aschmann Y; Kummer O; Rätz Bravo AE; Bodmer M
    Praxis (Bern 1994); 2007 Apr; 96(17):673-6; quiz 677-8. PubMed ID: 17491196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic acute tubular necrosis following treatment with zoledronate (Zometa).
    Markowitz GS; Fine PL; Stack JI; Kunis CL; Radhakrishnan J; Palecki W; Park J; Nasr SH; Hoh S; Siegel DS; D'Agati VD
    Kidney Int; 2003 Jul; 64(1):281-9. PubMed ID: 12787420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
    Houston S; Grieve RJ; Hickish T; Percival F; Hamilton E
    J Med Econ; 2010 Mar; 13(1):162-7. PubMed ID: 20136578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases.
    Luedders DW; Steinhoff J; Thill M; Rody A; Bohlmann MK
    Anticancer Res; 2015 Mar; 35(3):1797-802. PubMed ID: 25750345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine-associated interstitial nephritis and Fanconi syndrome.
    Neelakantappa K; Gallo GR; Lowenstein J
    Am J Kidney Dis; 1993 Aug; 22(2):333-6. PubMed ID: 8352262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases.
    Janssen van Doorn K; Neyns B; Van der Niepen P; Verbeelen D
    Nephron; 2001 Dec; 89(4):467-8. PubMed ID: 11721169
    [No Abstract]   [Full Text] [Related]  

  • 35. Relapsing Tubulointerstitial Nephritis with Antimitochondrial M2 Antibody Accompanied by Pulmonary Involvement.
    Nakamori A; Akagaki F; Yamaguchi Y; Sugiura T
    Intern Med; 2020 May; 59(9):1179-1187. PubMed ID: 32051384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).
    von Minckwitz G; Rezai M; Tesch H; Huober J; Gerber B; Zahm DM; Hilfrich J; Costa SD; Dubsky P; Blohmer JU; Denkert C; Hanusch C; Jackisch C; Kümmel S; Fasching PA; Schneeweiss A; Paepke S; Untch M; Burchardi N; Mehta K; Loibl S;
    Eur J Cancer; 2016 Sep; 64():12-21. PubMed ID: 27323347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoledronate-related osteonecrosis of the mandible.
    Ho L; Quan V; Henderson R
    Clin Nucl Med; 2008 Jan; 33(1):68-70. PubMed ID: 18097268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D
    Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer.
    Jacobs C; Kuchuk I; Bouganim N; Smith S; Mazzarello S; Vandermeer L; Dranitsaris G; Dent S; Gertler S; Verma S; Song X; Simos S; Cella D; Clemons M
    Breast Cancer Res Treat; 2016 Jan; 155(1):77-84. PubMed ID: 26643085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.